Preview

Malignant tumours

Advanced search

Treatment results of hand and foot soft tissue sarcomas in Moscow oncology hospital № 62 of the Moscow health department

https://doi.org/10.18027/2224-5057-2024-017

Abstract

Introduction: Soft tissue sarcomas (STS) of the distal extremities are a rare heterogeneous group of malignant mesenchymal tissue tumors, and the publications are extremely limited. They require a special approach because of their small size and functional significance of the areas in which they are located.

The aim of our research was to analyze the clinical and morphological characteristics of hand and foot soft tissue sarcomas and to evaluate the results of treatment depending on various factors.

Materials and methods: We conducted a retrospective analysis of clinical observations of 50 patients with hand and foot soft tissue sarcomas who were examined and treated from 2004 to 2023 at the Moscow Oncology Hospital № 62.

Results: 50 patients with soft tissue sarcomas of the hand and foot were included in this study. There were 24 men and 26 women with a mean age of 45 years. Of the 50 sarcomas, 12 were localized on the hands and 36-on the feet. The commonest subtypes were epithelioid sarcoma in the hand and synovial sarcoma in the foot. The 5-year overall survival (OS) was 55.9%. There were no significant differences in OS or progression-free survival (PFS) among patients treated at a general hospital. 5-year OS in the group of the phalanx sarcoma was significantly higher (p = 0.025). Phalanx sarcomas were more often 5 cm or smaller in size (p = 0.007), but larger tumor size (> 5 cm) was not associated with lower survival. OS significantly decreased in proportion to increasing stage.

Conclusion: Most hand and foot soft tissue sarcomas were less than 5 cm in size, which is indicating that it should not be used as a diagnostic threshold in the distal extremity region. Five-year OS in patients with soft tissue sarcomas of the phalanges is higher than in patients with sarcomas of more proximal localizations.

About the Authors

E. I. Gribkova
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University); Moscow Oncology Hospital № 62 of the Moscow Health Department
Russian Federation

Gribkova Elizaveta Igorevna

Build. 2, 8 Trubetskaya St., Moscow 119991


Competing Interests:

The authors declare that there are no possible conflicts of interest



E. R. Musaev
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University); Moscow Oncology Hospital № 62 of the Moscow Health Department
Russian Federation

Musaev Elmar Rasim ogly

Build. 2, 8 Trubetskaya St., Moscow 119991


Competing Interests:

The authors declare that there are no possible conflicts of interest



M. M. Davydov
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Russian Federation

Davydov Mikhail Mikhailovich

Build. 2, 8 Trubetskaya St., Moscow 119991


Competing Interests:

The authors declare that there are no possible conflicts of interest



A. T. Abdulzhaliev
Moscow Oncology Hospital № 62 of the Moscow Health Department
Russian Federation

Abdulzhaliev Adil Takhirovich

Moscow


Competing Interests:

The authors declare that there are no possible conflicts of interest



References

1. The state of cancer care for the population of Russia in 2022. Eds.: A.D. Kaprin, V.V. Starinskiy, A.O. Shachzadova. Moscow: MNIOI im. P.A. Gertsena filial FGBU “NMITS radiologii” Minzdrava Rossii, 2022.239 p (In Russ.)

2. Mattei J.C., Brouste V., Terrier P., et al. Distal extremities soft tissue sarcomas: Are they so different from other limb localizations? J Surg Oncol 2019;119(4):479-488. https://doi.org/10.1002/jso.25359

3. Sarcoma and Gastrointestinal Stromal Tumours plus Cancer of Unknown Primary Site Essentials for Clinicians 2020. Online. Available at: www.esmo.org

4. Dangoor A., Seddon B., Gerrand C., et al. UK guidelines for the management of soft tissue sarcomas. Clin Sarcoma Res 2016;6:20. https://doi.org/10.1186/sl3569-016-0060-4

5. Dean B.J.F., Branford-White H., Giele H., et al. Management and outcome of acral soft-tissue sarcomas. Bone Joint J 2018;100-B(ll):1518-1523. https://doi.org/10.1302/0301-620X.100Bll.BJJ-2018-0301.Rl

6. Lans J., Yue K.C., Castelein R.M., et al. Soft tissue sarcoma of the hand: Is unplanned excision a problem? Eur J Surg Oncol 2019;45(7):1281-1287. https://doi.Org/10.1016/j.ejso.2019.03.024. Erratum in: Eur J Surg Oncol. 2021 May;47(5):1232

7. Ahmed S.K., Kaggal S., Harmsen W.S., et al. Patient-reported functional outcomes in a cohort of hand and foot sarcoma survivors treated with limb sparing surgery and radiation therapy. J Surg Oncol 2021;123(l):110-116. https://doi.org/10.1002/jso.26258

8. NCCN Guidelines Version 2.2023 Soft Tissue Sarcoma. 2023. Available at: https://www.nccn.org/guidelines/guidelinesdetail?category=l&id=1464

9. Clinical Guidelines. Soft tissue sarcomas, 2022. Available at: https://cr.minzdrav.gov.ru/recomend/515_2 (In Russ.)

10. Gronchi A., Miah A.B., Dei Tos A.P., et al. Soft tissue and visceral sarcomas: ESMO-EURACAN'GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2021;32(ll):1348-1365. https://doi.org/10.1016/j.annonc.2021.07.006

11. Pradhan A., Cheung Y.C., Grimer R.J., et al. Soft-tissue sarcomas of the hand: oncological outcome and prognostic factors.J Bone joint Surg Br 2008;90(2):209-14. https://doi.org/10.1302/0301-620X.90B2.19601

12. Houdek M.T., Walczak B.E., Wilke B.K., et al. What factors influence the outcome of surgically treated soft tissue sarcomas of the hand and wrist? Hand (N Y) 2017;12(5):493-500. https://doi.org/10.1177/1558944716672197

13. Kozawa E., Nishida Y., Nakashima H., et al. Foot sarcomas: Factors affecting oncological and functional outcomes. Oncol Lett 2012;3(l):82-88. https://doi.org/10.3892/ol.2011.427

14. Gassert F.G., Gassert F.T., Specht K., et al. Soft tissue masses: distribution of entities and rate of malignancy in small lesions. BMC Cancer 2021;21(l):93. https://doi.org/10.1186/sl2885-020-07769-2

15. Houdek M.T., Beahrs T.R., Wyles C.C., et al. What factors are predictive of outcome in the treatment of soft tissue sarcomas of the foot and ankle? Foot Ankle Spec 2017;10(l):12—19. https://doi.org/10.1177/1938640016666925

16. Zeytoonjian T., Mankin H.J., Gebhardt M.C., Hornicek F.J. Distal lower extremity sarcomas: frequency of occurrence and patient survival rate. Foot Ankle Int 2004;25(5):325—30. https://doi.org/10.1177/107110070402500509

17. Murahashi Y., Iba K., Teramoto A., et al. Clinical features of bone and soft tissue tumors of the foot and ankle: Results from a retrospective single-center case-series. J Orthop Sci 2021;26(5):885-890. https://doi.Org/10.1016/j.jos.2020.08.016

18. Harati K., Kirchhoff P., Behr B., et al. Soft tissue sarcomas of the distal lower extremities: A single-institutional analysis of the prognostic significance of surgical margins in 120 patients. Oncol Rep 2016;36(2):863-70. https://doi.org/10.3892/or.2016.4862

19. Dadras M., Steinau H.U., Goertz O., et al. Limb preserving surgery for soft-tissue sarcoma in the hand: a retrospective study of 51 cases. J Hand Surg Eur Vol 2020;45(6):629—635. https://doi.org/10.1177/1753193419899037

20. Salipas A., Dowsey M.M., May D., et al. ‘Beware the lump in the foot!’: predictors of recurrence and survival in bone and soft-tissue sarcomas of the foot and ankle. ANZJ Surg 2014;84(7—8):533—8. https://doi.org/10.llll/ans.12593.


Review

For citations:


Gribkova E.I., Musaev E.R., Davydov M.M., Abdulzhaliev A.T. Treatment results of hand and foot soft tissue sarcomas in Moscow oncology hospital № 62 of the Moscow health department. Malignant tumours. 2024;14(3):31-39. (In Russ.) https://doi.org/10.18027/2224-5057-2024-017

Views: 172


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2224-5057 (Print)
ISSN 2587-6813 (Online)